Aeropalynological monitoring of weed pollen and mold spores
DOI: 10.32364/2587-6821-2020-4-1-48-51
O.P. Ukhanova1, M.A. Bogdanova1, I.V. Zheltova2, A.A. Yudin3, F.A. Shcherbinin3
1Stavropol State Medical University, Stavropol, Russian Federation
2City Polyclinics No. 1, Nevinnomyssk, Russian Federation
3LLC “Terapharm”, Stavropol, Russian Federation
Ambrosia pollen is one of the dominant pollen taxa causing pollinosis in humans. In Europe, sensitization to ragweed pollen ranges from 2.5% to 60%. According to forecasts by 2041–2060. sensitization to ragweed will be widespread throughout Europe, threatening an epidemic of ragweed pollen allergy. Stavropol region is endemic since 80% of the land is affected by Ambrosia (i.e., Ambrosia artemisiifolia and Ambrosia trifida). Even low pollen load (less than 5 pg/m3) can cause respiratory allergic symptoms. Ambrosia count of 10–20 grains/m3 may induce asthma exacerbations.
The authors have analyzed aeropalynological studies and have described for the first time pollen spectrum in the atmospheric air during weed vegetation period (including quarantine weed Ambrosia) and mold sporulation period. The dynamics of ragweed pollination in August-September 2019 depending on meteorological conditions was recorded. These findings were applied to create a calendar of weed pollination and mold sporulation in Stavropol. The results of aeropalynological studies can be further used by allergists and immunologists in daily practice to control respiratory allergic diseases and to improve both preventive and therapeutic measures.
Keywords: pollen monitoring, pollen allergy, ragweed, pollen calendar mold spores.
For citation: Ukhanova O.P., Bogdanova M.A., Zheltova I.V. et al. Aeropalynological monitoring of weed pollen and mold spores. Russian Medical Review. 2020;4(1):48–51. DOI: 10.32364/2587-6821-2020-4-1-48-51.
About the authors:
1Olga P. Ukhanova — MD, PhD, Professor of the Department of Immunology with the Course of Postgraduate Education, allergist and immunologist, ORCID iD 0000-0002-7247-0621;
1Mariya A. Bogdanova — MD, postgraduate student of the Department of Immunology with the Course of Postgraduate Education, ORCID iD 0000-0002-3184-1326;
2Irina V. Zheltova — MD, allergist and immunologist, ORCID iD 0000-0002-3408-157X;
3Aleskandr A. Yudin — male nurse, ORCID iD 0000-0003-1061-5626;
3Filipp A. Shcherbinin — coordinator, ORCID iD 0000-0001-9350-3085.
1Stavropol State Medical University. 310, Mira str., Stavropol, 355017, Russian Federation.
2City Polyclinics No. 1 of Nevinnomyssk. 33, Nizyaev str., Nevinnomyssk, 357107, Russian Federation.
3LLC “Terapharm”. 31A, Sevryukov str., Stavropol, 355000, Russian Federation.
Contact information: Olga P. Ukhanova, e-mail: uhanova_1976@mail.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 04.02.2020.
2. Chen K.W., Marusciac L., Tamas P.T. et al. Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe. Int Arch Allergy Immunol. 2018;176(3–4):163–180. DOI: 10.1159/000487997.
3. Резник С.Я. Амброзия обыкновенная (Ambrosia artemisiifolia L.) в России: распространение, изобилие, вред и меры контроля. Амброзия обыкновенная. Первое международное обозрение амброзии. РАН, Зоологический институт. 2009;26:88–97. [Reznik S. Ya. Common Ambrosia (Ambrosia artemisiifolia L.) in Russia: distribution, abundance, harm and control measures. Ambrosia common is the first international ragweed review. Russian Academy of Sciences, Zoological Institute. 2009;26:88–97 (in Russ.)].
4. European ragweed pollen load maps obtained from European Allergen Network (provided by Medical University of Vienna) with the permission to use. (Elrctronic resourse). URL: https://www.polleninfo.org/country-choose.html. Access date: 28.12.2019.
5. Tosi A., Wüthrich B., Bonini M., Pietragalla-Köhler B. Time lag between Ambrosia sensitisation and Ambrosia allergy: a 20-year study (1989–2008) in Legnano, northern Italy. Swiss Med. Wkly. 2011;141:115–126. DOI: 10.4414/smw.2011.13253.
6. Погода в Ставрополе на август 2019. (Электронный ресурс). URL: https://avgust-2019.meteogu.ru/rus/stavropolskij_kraj/stavropol/. Дата обращения: 28.12.2019. [Weather in Stavropol in August 2019. (Elrctronic resourse). URL: https://sentyabr-2019.meteogu.ru/rus/stavropolskij_kraj/stavropol/ Access date: 28.12.2019 (in Russ.)].
7. Погода в Ставрополе на cентябрь 2019. (Электронный ресурс). URL: https://sentyabr-2019.meteogu.ru/rus/stavropolskij_kraj/stavropol/. Дата обращения: 28.12.2019. [Weather in Stavropol in September 2019. (Elrctronic resourse). URL: https://sentyabr-2019.meteogu.ru/rus/stavropolskij_kraj/stavropol/ Access date: 28.12.2019 (in Russ.)].
8. Nolte H., Hébert J., Berman G. et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann. Allergy Asthma Immunol. 2013;110:450–456. DOI: 10.1016/j.anai.2013.03.013.
9. Creticos P.S., Maloney J., Bernstein D.I. et al. Efficacy and safety of ragweed SLIT-tb in NA and EU adults. J Allergy Clin Immunol. 2013;131:1342–1349. DOI: 10.1016/j.jaci.2013.03.019.
10. Maloney J., Berman G., Gagnon R. et al. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated. J Allergy Clin Immunol Pract. 2016;4:301–309. DOI: 10.1016/j.jaip.2015.11.004.
11. Nolte H., Amar N., Bernstein D.I. et al. Safety and tolerability of a short ragweed sublingual immunotherapy tablet. Ann. Allergy Asthma Immunol. 2014;113:93–100. DOI: 10.1016/j.anai.2014.04.018.
12. Kim H., Waserman S., Hébert J. et al. Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis. Allergy Asthma Clin Immunol. 2014;10:10–55. DOI: 10.1186/1710-1492-10-55.
13. Nelson H.S. Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek) for the treatment of allergic rhinitis. Expert Rev Clin Immunol. 2018;14(12):1003–1011. DOI: 10.1080/1744666X.2018.1538788.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
